Table 4.
Clinical outcomes of patients(Group 1: Early treatment with FPV and HQ, Group 2: Late treatment with FPV and HQ, Group 3: Treatment with only HQ)
| Clinic outcomes | Group 1 | Group 2 | Group 3 | p-value |
|---|---|---|---|---|
| ARDS | 6a (12.5%) | 10b (20.8%) | 0a,b (0.0%) |
0.005a 0.005b |
| ICU | 13c (27.1%) | 13d (27.1%) | 1c,d (2.1%) |
0.001c 0.001d |
| Intubation | 2 (4.2%) | 4 (8.3%) | 0 (0.0%) | NS |
| Death | 2 (4.2%) | 4 (8.3%) | 0 (0.0%) | NS |
Statistically significant values are presented in bold. Superscript letters define the significant p-values of pairwise comparisons. Tukey's test and Games Howell tests were preferred as posthoc tests
ARDS acute respiratory distress syndrome; ICU ıntensive care unit
a denotes the comparison of patients with ARDS in Group 1 vs. Group 3
b denotes the comparison of patients with ARDS in Group 2 vs. Group 3
c denotes the comparison of patients with ICU in Group 1 vs. Group 3
d denotes the comparison of patients with ICU in Group 2 vs. Group 3